AqueSys: Allergan PLC Acquisition Frenzy Continues

Allergan Inc. (NYSE:AGN) continues its acquisition spree, as the biotech firm announced that it would be acquiring a private clinical-stage medical device company, AqueSys Inc., in a deal worth $300 million. The acquisition would build on Allergan's efforts to expand its eye care portfolio.